Buscar
-
Understanding factors associated with the trajectory of subjective cognitive complaints in groups with similar objective cognitive trajectories
(Alzheimer's research & therapy. vol. 15, n° 1, pp. 205, 2023-11-22)Article de revueLibre acceso -
Describing complex disease progression using joint latent class models for multivariate longitudinal markers and clinical endpoints.
(Statistics in Medicine. vol. 42, n° 22, pp. 3996-4014, 2023-09-30)Article de revueLibre acceso -
Disease progression model anchored around clinical diagnosis in longitudinal cohorts: example of Alzheimer's disease and related dementia
(BMC Medical Research Methodology. vol. 23, n° 1, pp. 199, 2023-09-05)Article de revueLibre acceso -
Disease Progression in Multiple System Atrophy: The Value of Clinical Cohorts with Long Follow-Up
(Movement disorders. vol. 38, n° 8, pp. 1567-1569, 2023-08-01)Article de revueLibre acceso -
Outcomes of targeted treatment in immunocompromised patients with asymptomatic or mild COVID-19: a retrospective study
(Scientific Reports. vol. 13, n° 1, pp. 15357, 2023-09-16)Article de revueLibre acceso -
Foodborne botulism outbreak involving different nationalities during the Rugby World Cup: critical role of credit card data and rapid international cooperation, France, September 2023
(Euro surveillance. vol. 28, n° 47, 2023-11)Article de revueLibre acceso -
Balance between neutrophil extracellular trap formation and DNase activity in COVID-19 patients: a prospective cohort study
Communication dans un congrès -
Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV
(Cancers. vol. 15, n° 14, 2023-07-15)Article de revueLibre acceso -
External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection
(Journal of Hepatology. vol. 78, n° 5, pp. 947-957, 2023-01-20)Article de revueLibre acceso -
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone
(Lancet Global Health. vol. 11, n° 11, pp. e1743-e1752, 2023-11)Article de revueLibre acceso